1. Home
  2. AIHS vs SHPH Comparison

AIHS vs SHPH Comparison

Compare AIHS & SHPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

AIHS

Senmiao Technology Limited

N/A

Current Price

$1.17

Market Cap

5.7M

Sector

Finance

ML Signal

N/A

Logo Shuttle Pharmaceuticals Holdings Inc.

SHPH

Shuttle Pharmaceuticals Holdings Inc.

HOLD

Current Price

$0.78

Market Cap

5.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AIHS
SHPH
Founded
2014
2012
Country
China
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.7M
5.2M
IPO Year
2017
2022

Fundamental Metrics

Financial Performance
Metric
AIHS
SHPH
Price
$1.17
$0.78
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
14.0K
1.1M
Earning Date
02-13-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
14.63
N/A
EPS
N/A
N/A
Revenue
$3,389,072.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.25
$0.12
52 Week High
$8.26
$5.59

Technical Indicators

Market Signals
Indicator
AIHS
SHPH
Relative Strength Index (RSI) 44.09 42.74
Support Level $1.10 $0.58
Resistance Level $1.28 $1.13
Average True Range (ATR) 0.10 0.16
MACD -0.01 -0.02
Stochastic Oscillator 24.21 18.88

Price Performance

Historical Comparison
AIHS
SHPH

About AIHS Senmiao Technology Limited

Senmiao Technology Ltd is a holding company. Along with its subsidiaries, it is engaged in facilitating automobile transactions and offering related services. The group's business activities include providing car rental services to individual customers with lease term no more than twelve months; leasing and servicing of new energy vehicles; offering services to automobile purchasers throughout the purchase process; providing management and related services to Partner Platforms and other companies; automobile financing; and providing other related supporting services to customers. The majority of the group's revenue is generated from its automobile rental business.

About SHPH Shuttle Pharmaceuticals Holdings Inc.

Shuttle Pharmaceuticals Holdings Inc is a clinical-stage pharmaceutical company leveraging its proprietary technology to develop novel therapies designed to cure cancers. The company has one operating segment with a focus on the development of novel drug therapies, including cancer therapies, extending new applications of radiation therapy, and other drug development, including through the use of the Molecule.ai platform by the company as well as licensing the right to use Molecuile.ai to others. The company's goal is to extend the benefits of cancer treatments with surgery, radiation therapy, chemotherapy and immunotherapy. Radiation therapy (RT) is one of the effective modalities for treating cancers. Its pipeline includes: Ropidoxuridine, HDAC Inhibitors, PSMA-B, and PC-Rad Test.

Share on Social Networks: